<DOC>
	<DOCNO>NCT00901199</DOCNO>
	<brief_summary>This small pilot study look safety give combination chelation Exjade Desferal 15 patient . The hypothesis combination chelation safe decrease overall iron patient thalassemia .</brief_summary>
	<brief_title>Combo Chelation Trial</brief_title>
	<detailed_description />
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Iron Overload</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Deferasirox</mesh_term>
	<mesh_term>Deferoxamine</mesh_term>
	<criteria>Transfusion Dependent Thalassemia If iron 515 mg/g dry liver SQUID , subject must document endocrinopathy cardiac find Older 8 year Participating another interventional clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Thalassemia</keyword>
	<keyword>Chelation</keyword>
	<keyword>Iron Overload</keyword>
	<keyword>Thalassemia patient Iron overload</keyword>
</DOC>